BBIO
BridgeBio Pharma Inc.
$51.65
+$0.11(+0.21%)
81
Overall
--
Value
81
Tech
--
Quality
Market Cap
$9.84B
Volume
1.11M
52W Range
$21.72 - $54.60
Target Price
$65.14
EPS Estimates Overview
| Current Quarter | $-0.69 | Next Quarter | $-0.78 |
| Current Year | $-3.28 | Next Year | $-2.05 |
| QoQ Growth | -13.0% | YoY Growth | +37.5% |
| 3Y EPS CAGR | +9.6% | Target Price | $65.14 |
| Consensus | Buy | Upside | +26.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $51.65 | +0.2% | 1.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |